ancrod treatment resulted in fibrinogen levels less than 50 mg/dl without bleeding , decrease of previously elevated factor viii and von willebrand factor levels , and normalization of in vitro platelet hyperaggregation .
C0019080
bleeding
C0042971
von willebrand